SHAZ Surges 44.6% on AI Capacity Expansion; SNDK, ACB, CLMT, NYXH Follow
Shares of SharonAI Holdings (SHAZ) jumped 44.6% since August 7, driven by a massive AI capacity expansion and a $4.9 billion NVIDIA collaboration. Sandisk (SNDK) climbed 26.1% after unveiling aggressive long-term margin targets, while Aurora Cannabis (ACB) gained 27.2% following an EPS estimate revision and shareholder approval. Calumet (CLMT) and Nyxoah (NYXH) also posted double-digit gains on robust earnings and strategic developments.
| Ticker | Sector | Detected | EPS Revision | Gain Since Detection |
|---|---|---|---|---|
| SHAZ | Technology | 2026-08-07 | N/A | +44.6% |
| ACB | Healthcare | 2026-08-06 | +16.1pp | +27.2% |
| SNDK | Technology | 2026-08-07 | N/A | +26.1% |
| CLMT | Basic Materials | 2026-08-09 | +11.7pp | +23.6% |
| NYXH | Healthcare | 2026-08-06 | +7.0pp | +20.6% |
Why did SHAZ stock jump in August 2026?
SHAZ jumped 44.6% (from $49.79 to $72.02) after analysts raised its next-year EPS growth estimate to 86.2% on August 7.
The surge was reinforced by Q2 earnings that revealed AI factory capacity surged to 212MW and a $4.9 billion six-year NVIDIA compute collaboration. The company's contracted revenue book grew to roughly $8.8 billion, with demand outpacing supply and GPU pricing at record levels over $4 per hour. Investors are betting on the revenue recognition ramp expected in Q4 2026.
SHAZ EPS revision history → · Screener snapshot from 2026-08-07 →
FAQ: SHAZ
Why did SHAZ stock jump?
SHAZ jumped 44.6% after analysts revised its EPS growth estimate to 86.2% and the company reported a massive AI capacity expansion to 212MW.
Is SHAZ a buy after the rally?
SHAZ's rally is supported by a $4.9 billion NVIDIA deal and $8.8 billion contracted revenue, but revenue recognition won't start until Q4 2026, so investors should weigh execution risks.
What caused SHAZ's surge?
The surge was driven by Q2 earnings showing AI capacity jumped to 212MW, a $4.9 billion NVIDIA collaboration, and a raised EPS growth estimate of 86.2%.
Why did ACB stock jump in August 2026?
ACB jumped 27.2% (from $2.98 to $3.79) after analysts raised its next-year EPS growth estimate from 91.5% to 107.5% on August 6.
The move was supported by shareholder approval of its medical-first strategy at the annual meeting, with 82.97% voting in favor of executive compensation. The company's focus on strengthening its global medical cannabis business is resonating with investors, who see the EPS revision as a sign of accelerating profitability.
ACB EPS revision history → · Screener snapshot from 2026-08-06 →
FAQ: ACB
Is ACB a buy after the rally?
ACB's 27.2% rally reflects a 16.1 percentage point upward EPS revision, but its 107.5% growth estimate is high, so investors should monitor execution of the medical-first strategy.
What caused ACB's surge?
ACB rose 27.2% after analysts revised its next-year EPS growth upward to 107.5%, with investors also encouraged by shareholder support at the AGM.
What is ACB's EPS growth estimate?
ACB's next-year EPS growth estimate is 107.5%, up from 91.5%.
Why did SNDK stock jump in August 2026?
SNDK jumped 26.1% (from $1212.21 to $1528.11) after analysts raised its next-year EPS growth estimate to 25.6% on August 7.
The rally accelerated on August 13 when SanDisk's Investor Day outlined targets for 80% gross margins and 50% free cash flow margins through fiscal 2030, lifting the entire memory sector. The company's long-term supply agreements covering two-thirds of bits shipped by fiscal 2028 and expanding AI inference workloads underpinned the bullish outlook.
SNDK EPS revision history → · Screener snapshot from 2026-08-07 →
FAQ: SNDK
Why did SNDK stock jump?
SNDK jumped 26.1% after analysts revised its EPS growth estimate to 25.6% and the company unveiled aggressive long-term margin targets at its Investor Day.
What caused SNDK's surge?
The surge was driven by the Investor Day announcement of 80% gross margins and 50% free cash flow margins, which also boosted other memory stocks like Micron and Western Digital.
What is SNDK's EPS growth estimate?
SNDK's next-year EPS growth estimate is 25.6%.
Why did CLMT stock jump in August 2026?
CLMT jumped 23.6% (from $39.48 to $48.79) after analysts raised its next-year EPS growth estimate from 159.1% to 170.8% on August 9.
The strong performance was underpinned by Q2 adjusted EBITDA of $175 million despite planned turnarounds, driven by a structurally imbalanced global base oil market with over 10% of capacity offline. The company also reduced leverage below 4x and identified a lower-risk path for SAF production expansion, boosting investor confidence.
CLMT EPS revision history → · Screener snapshot from 2026-08-09 →
FAQ: CLMT
Why did CLMT stock jump?
CLMT jumped 23.6% after analysts raised its next-year EPS growth estimate to 170.8% and the company reported strong Q2 EBITDA amid tight base oil markets.
What caused CLMT's surge?
The surge was driven by a 11.7 percentage point EPS revision and Q2 results showing $175 million adjusted EBITDA, supported by global base oil capacity disruptions.
What is CLMT's EPS growth estimate?
CLMT's next-year EPS growth estimate is 170.8%.
Why did NYXH stock jump in August 2026?
NYXH jumped 20.6% (from $1.31 to $1.58) after analysts raised its next-year EPS growth estimate from 27.8% to 34.8% on August 6.
The rally followed Q2 results showing a 22% sequential increase in US revenue to EUR5.2 million and a doubling of active accounts to 180. The company also secured $110 million in financing and benefited from proposed CMS reimbursement increases for its Genio procedure, removing a major overhang.
NYXH EPS revision history → · Screener snapshot from 2026-08-06 →
FAQ: NYXH
Why did NYXH stock jump?
NYXH jumped 20.6% after analysts revised its EPS growth estimate to 34.8% and Q2 results showed strong US revenue growth of 22% sequentially.
What caused NYXH's surge?
The surge was driven by the EPS revision, better-than-expected US revenue growth, $110 million in new financing, and proposed CMS reimbursement increases.
What is NYXH's EPS growth estimate?
NYXH's next-year EPS growth estimate is 34.8%.
Today's top movers were all tied to upward EPS revisions, with AI infrastructure (SHAZ), memory/storage (SNDK), and medical cannabis (ACB) leading the charge. The market is rewarding companies that can demonstrate clear, long-term growth catalysts, particularly in AI-driven sectors.
How We Identify These Stocks
We track daily changes in forward EPS estimates across thousands of US equities. When a stock's next-year earnings growth estimate is revised upward — confirmed by improvement in current-year estimates — it enters our watchlist. The stocks above were flagged on their detection dates and have since delivered the strongest price returns among all detected stocks.
Explore today's full screener →